Please Wait.....
Report
NA Venous Diseases Treatment Market - Industry Trends and Forecast to 2030
Market Report I 2023-02-01 I 222 Pages I Data Bridge Market Research
North America venous diseases treatment market is projected to register a CAGR of 7.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
North America Venous Diseases Treatment Market, By Product Type (Ablation Devices, Venous Stents, Venous Closure Products, Sclerotherapy Injection and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins and Others), Treatment Type (Surgeries, Scelrotherapy, Angioplasty Or Stenting, Vein Legation and Stripping, Vena Cava Filter, Ambulatory Phlebectomy, Radiofrequency Ablation Therapy, Laser Treatment and Other Therapies) End User (Hospitals, Clinics, Ambulatory Surgical Centers and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the venous diseases treatment market are:
- Rapid changes in lifestyle leads to obesity resulting in venous diseases
- Increase in the geriatric population
- Rising awareness towards venous disorders
Market Players:
The key market players for North America venous diseases treatment market are listed below:
- Abbott
- Alma Lasers
- Angiodynamics
- B.Braun Melsungen AG
- Baylis Medical Company, Inc
- BD
- Boston Scientific Corporation
- Candela Medical
- Carl Zeiss Meditec AG
- Cook
- Imricor
- Koninklijke Philips N.V.
- Medtronic
- Olympus Corporation
- Plusmedica.de
- Smith + Nephew
- Sonablate
- Stryker
- Teleflex Incorporated
- Terumo Corporation
- Theraclion
- Varian Medical Systems, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 51
1.1 OBJECTIVES OF THE STUDY 51
1.2 MARKET DEFINITION 51
1.3 OVERVIEW OF THE NORTH AMERICA VENOUS DISEASES TREATMENT MARKET 51
1.4 CURRENCY AND PRICING 53
1.5 LIMITATIONS 54
1.6 MARKETS COVERED 54
2 MARKET SEGMENTATION 59
2.1 MARKETS COVERED 59
2.2 GEOGRAPHICAL SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 DBMR TRIPOD DATA VALIDATION MODEL 62
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 65
2.6 MULTIVARIATE MODELLING 66
2.7 MARKET END USER COVERAGE GRID 67
2.8 INSTRUMENT BASED LIFELINE CURVE 68
2.9 DBMR MARKET POSITION GRID 69
2.10 VENDOR SHARE ANALYSIS 71
2.11 SECONDARY SOURCES 72
2.12 ASSUMPTIONS 72
3 EXECUTIVE SUMMARY 73
4 PREMIUM INSIGHTS 76
4.1 PESTEL ANALYSIS 77
4.2 PORTER'S FIVE FORCES 78
5 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, INDUSTRY INSIGHTS 79
6 EPIDEMIOLOGY 81
7 REGULATORY FRAMEWORK 82
8 MARKET OVERVIEW 85
8.1 DRIVERS 87
8.1.1 RISING INCIDENCES OF VENOUS DISEASES 87
8.1.2 RAPID CHANGES IN LIFESTYLE LEAD TO OBESITY RESULTING IN VENOUS DISEASES 87
8.1.3 INCREASE IN THE GERIATRIC POPULATION 88
8.1.4 TECHNOLOGICALLY ADVANCEMENT IN THE TREATMENT OF VENOUS DISEASES 89
8.2 RESTRAINTS 90
8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 90
8.2.2 INADEQUATE REIMBURSEMENT COVERAGE 90
8.3 OPPORTUNITIES 91
8.3.1 RISING AWARENESS TOWARDS VENOUS DISORDERS 91
8.3.2 NEED FOR PROPER DIAGNOSIS AND TREATMENT OF VENOUS DISEASES 91
8.3.3 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES 92
8.3.4 OCCUPATIONAL LIFESTYLE INCREASES THE NEED FOR VENOUS DISEASE TREATMENT 92
8.4 CHALLENGES 93
8.4.1 HIGH COST ASSOCIATED WITH VENOUS DISEASE TREATMENT 93
8.4.2 SIDE EFFECTS AND RISK ASSOCIATED WITH DIFFERENT TREATMENT MODES 94
9 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE 95
9.1 OVERVIEW 96
9.2 SCLEROTHERAPY INJECTION 99
9.2.1 SCLEROTHERAPY, BY TYPE 99
9.2.1.1 INTRAVENOUS 100
9.2.1.2 INTRADERMAL 100
9.2.1.3 SUBCUTANEOUS 100
9.2.2 SUBCUTANEOUS, BY APPLICATION 100
9.2.2.1 MALFORMED LYMPHED VESSELS 100
9.2.2.2 HEMORRHOIDS 100
9.2.2.3 HYDROCELES 100
9.2.2.4 OTHERS 100
9.3 ABLATION DEVICES 100
9.3.1 THERMAL ABLATION 101
9.3.1.1 RADIOFREQUENCY 102
9.3.1.1.1 CATHETER MANIPULATION SYSTEMS 102
9.3.1.1.2 TEMPERATURE CONTROLLED 102
9.3.1.1.3 FLUID COOLED 103
9.3.1.2 LIGHT 103
9.3.1.2.1 EXCIMER LASERS 103
9.3.1.2.2 COLD LASERS 103
9.3.1.3 ULTRASOUND 103
9.3.1.3.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) 104
9.3.1.3.2 SHOCK WAVE LITHOTRIPSY 104
9.3.1.3.3 MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND (MRI-FUS) 104
9.3.1.3.4 ULTRASONIC SURGICAL SYSTEMS 104
9.3.1.4 RADIATION 104
9.3.1.4.1 STEREOTACTIC BODY RADIATION THERAPY 105
9.3.1.4.2 INTENSITY-MODULATED RADIATION THERAPY 105
9.3.1.4.3 STEREOTACTIC RADIOTHERAPY & RADIOSURGERY 105
9.3.1.4.4 IMAGE GUIDED RADIATION THERAPY 105
9.3.1.4.5 INTRAVASCULAR BRACHYTHERAPY 105
9.3.1.4.6 PROTON BEAM THERAPY 105
9.3.1.5 ELECTRICAL 105
9.3.1.5.1 ELECTRICAL ABLATORS 106
9.3.1.5.2 ELECTRONIC BRACHYTHERAPY 106
9.3.1.6 MICROWAVE 106
9.3.1.7 HYDROTHERMAL 106
9.3.2 NON-THERMAL ABLATION 106
9.3.2.1 CRYOABLATION 106
9.3.2.1.1 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES 107
9.3.2.1.2 CRYOGEN SPRAY PROBE 107
9.3.2.1.3 TISSUE CONTACT PROBE 107
9.3.2.2 HYDROMECHANICAL ABLATION 107
9.4 VENOUS CLOSURE PRODUCTS 107
9.4.1 VENOUS CLOSURE PRODUCTS, BY PROCEDURE 108
9.4.1.1 INTERVENTIONAL CARDIOLOGY 108
9.4.1.2 INTERVENTIONAL RADIOLOGY 108
9.4.2 VENOUS CLOSURE PRODUCTS, BY TECHNOLOGY 108
9.4.2.1 FEMORAL ACCESS TECHNIQUE 109
9.4.2.2 RADIAL ACCESS TECHNIQUE 109
9.5 VENOUS STENTS 109
9.5.1 VENOUS STENTS, BY TECHNOLOGY 110
9.5.1.1 WALLSTENT TECHNOLOGY 110
9.5.1.2 ILIAC VEIN STENT TECHNOLOGY 110
9.5.2 VENOUS STENTS, BY APPLICATION 110
9.5.2.1 LEG 111
9.5.2.2 CHEST 111
9.5.2.3 ABDOMEN 111
9.5.2.4 OTHERS 111
9.6 MEDICATION 111
9.7 OTHERS 112
10 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE 113
10.1 OVERVIEW 114
10.2 VARICOSE VEINS 117
10.3 DEEP VEIN THROMBOSIS (DVT) 117
10.4 PULMONARY EMBOLISM 118
10.5 CHRONIC VENOUS INSUFFICIENCY (CVI) 119
10.6 SUPERFICIAL THROMBOPHLEBITIS 119
10.7 OTHERS 120
11 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE 122
11.1 OVERVIEW 123
11.2 SCLEROTHERAPY 126
11.3 RADIOFREQUENCY ABLATION THERAPY 126
11.4 LASER TREATMENT 127
11.5 AMBULATORY PHLEBECTOMY 128
11.6 VEIN LIGATION AND STRIPPING 128
11.7 ANGIOPLASTY OR STENTING 129
11.8 SURGERIES 130
11.9 COMPRESSION THERAPY 130
11.10 VEINACTIVE MEDICATION 131
11.11 VENA CAVA FILTER 132
11.12 OTHER THERAPIES 133
12 NORTH AMERICA VENOUS TREATMENT DISEASES MARKET, BY END USER 134
12.1 OVERVIEW 135
12.2 HOSPITALS 138
12.3 CLINICS 138
12.4 AMBULATORY SURGICAL CENTERS 139
12.5 OTHERS 140
13 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL 141
13.1 OVERVIEW 142
13.2 DIRECT TENDER 145
13.3 RETAIL SALES 145
13.4 OTHERS 146
14 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY REGION 147
14.1 NORTH AMERICA 148
14.1.1 U.S. 158
14.1.2 CANADA 164
14.1.3 MEXICO 170
15 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, COMPANY LANDSCAPE 176
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 176
16 SWOT ANALYSIS 177
17 COMPANY PROFILE 178
17.1 MEDTRONIC 178
17.1.1 COMPANY SNAPSHOT 178
17.1.2 REVENUE ANALYSIS 178
17.1.3 COMPANY SHARE ANALYSIS 179
17.1.4 PRODUCT PORTFOLIO 179
17.1.5 RECENT DEVELOPMENTS 179
17.2 BOSTON SCIENTIFIC CORPORATION 180
17.2.1 COMPANY SNAPSHOT 180
17.2.2 REVENUE ANALYSIS 180
17.2.3 COMPANY SHARE ANALYSIS 181
17.2.4 PRODUCT PORTFOLIO 181
17.2.5 RECENT DEVELOPMENTS 182
17.3 VARIAN MEDICAL SYSTEMS, INC. 183
17.3.1 COMPANY SNAPSHOT 183
17.3.2 COMPANY SHARE ANALYSIS 183
17.3.3 PRODUCT PORTFOLIO 184
17.3.4 RECENT DEVELOPMENT 184
17.4 STRYKER 185
17.4.1 COMPANY SNAPSHOT 185
17.4.2 REVENUE ANALYSIS 185
17.4.3 COMPANY SHARE ANALYSIS 186
17.4.4 PRODUCT PORTFOLIO 186
17.4.5 RECENT DEVELOPMENT 186
17.5 KONINKLIJKE PHILIPS N.V. 187
17.5.1 COMPANY SNAPSHOT 187
17.5.2 REVENUE ANALYSIS 187
17.5.3 COMPANY SHARE ANALYSIS 188
17.5.4 PRODUCT PORTFOLIO 188
17.5.5 RECENT DEVELOPMENT 188
17.6 ABBOTT 189
17.6.1 COMPANY SNAPSHOT 189
17.6.2 REVENUE ANALYSIS 189
17.6.3 PRODUCT PORTFOLIO 190
17.6.4 RECENT DEVELOPMENT 190
17.7 ALMA LASERS 191
17.7.1 COMPANY SNAPSHOT 191
17.7.2 PRODUCT PORTFOLIO 191
17.7.3 RECENT DEVELOPMENT 191
17.8 ANGIODYNAMICS 192
17.8.1 COMPANY SNAPSHOT 192
17.8.2 REVENUE ANALYSIS 192
17.8.3 PRODUCT PORTFOLIO 193
17.8.4 RECENT DEVELOPMENT 193
17.9 B.BRAUN MELSUNGEN AG 194
17.9.1 COMPANY SNAPSHOT 194
17.9.2 REVENUE ANALYSIS 194
17.9.3 PRODUCT PORTFOLIO 195
17.9.4 RECENT DEVELOPMENTS 195
17.10 BAYLIS MEDICAL COMPANY, INC 196
17.10.1 COMPANY SNAPSHOT 196
17.10.2 PRODUCT PORTFOLIO 196
17.10.3 RECENT DEVELOPMENT 196
17.11 BD 197
17.11.1 COMPANY SNAPSHOT 197
17.11.2 REVENUE ANALYSIS 197
17.11.3 PRODUCT PORTFOLIO 198
17.11.4 RECENT DEVELOPMENT 198
17.12 CANDELA MEDICAL 199
17.12.1 COMPANY SNAPSHOT 199
17.12.2 PRODUCT PORTFOLIO 199
17.12.3 RECENT DEVELOPMENT 199
17.13 CARL ZEISS MEDITEC AG 200
17.13.1 COMPANYSNAPSHOT 200
17.13.2 REVENUE ANALYSIS 200
17.13.3 PRODUCT PORTFOLIO 201
17.13.4 RECENT DEVELOPMENT 201
17.14 COOK 202
17.14.1 COMPANY SNAPSHOT 202
17.14.2 PRODUCT PORTFOLIO 202
17.14.3 RECENT DEVELOPMENTS 202
17.15 IMRICOR 203
17.15.1 COMPANY SNAPSHOT 203
17.15.2 REVENUE ANALYSIS 203
17.15.3 PRODUCT PORTFOLIO 204
17.15.4 RECENT DEVELOPMENT 204
17.16 OLYMPUS CORPORATION 205
17.16.1 COMPANY SNAPSHOT 205
17.16.2 REVENUE ANALYSIS 205
17.16.3 PRODUCT PORTFOILIO 206
17.16.4 RECENT DEVELOPMENT 206
17.17 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH 207
17.17.1 COMPANY SNAPSHOT 207
17.17.2 PRODUCT PORTFOLIO 207
17.17.3 RECENT DEVELOPMENTS 207
17.18 PLUSMEDICA.DE 208
17.18.1 COMPANY SNAPSHOT 208
17.18.2 PRODUCT PORTFOLIO 208
17.18.3 RECENT DEVELOPMENT 208
17.19 SCITECH 209
17.19.1 COMPANY SNAPSHOT 209
17.19.2 PRODUCT PORTFOLIO 209
17.19.3 RECENT DEVELOPMENTS 209
17.20 SMITH + NEPHEW 210
17.20.1 COMPANY SNAPSHOT 210
17.20.2 REVENUE ANALYSIS 210
17.20.3 PRODUCT PORTFOLIO 211
17.20.4 RECENT DEVELOPMENT 211
17.21 SONABLATE 212
17.21.1 COMPANY SNAPSHOT 212
17.21.2 PRODUCT PORTFOLIO 212
17.21.3 RECENT DEVELOPMENT 212
17.22 THERACLION 213
17.22.1 COMPANY SNAPSHOT 213
17.22.2 REVENUE ANALYSIS 213
17.22.3 PRODUCT PORTFOLIO 214
17.22.4 RECENT DEVELOPMENT 214
17.23 TELEFLEX INCORPORATED 215
17.23.1 COMPANY SNAPSHOT 215
17.23.2 REVENUE ANALYSIS 215
17.23.3 PRODUCT PORTFOLIO 216
17.23.4 RECENT DEVELOPMENTS 216
17.24 TERUMO CORPORATION 217
17.24.1 COMPANY SNAPSHOT 217
17.24.2 REVENUE ANALYSIS 217
17.24.3 PRODUCT PORTFOLIO 218
17.24.4 RECENT DEVELOPMENTS 218
18 QUESTIONNAIRE 219
19 RELATED REPORTS 222
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security